|Title:||Earmarking could be beneficial : cost-effectiveness is not the only criterion : round table discussion / Philip Musgrove|
|Context:||organization and administration|
|metadata.dc.subject.other:||Health Economics and Financing|
|Appears in Collections:||Journal Articles|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.